Altogether, our collective works suggest multiple potential IL6 sources within the TME that could jointly augment GP130-mediated MDM2 transcriptional upregulation – as well as other pro-cancer mechanisms driven by GP130 signaling independent of increasing MDM2 expression – consequently enhancing DDLPS pathogenicity. Here, IL6ST is linked to cancer.